KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
AcquisitionsCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Acquisitions & DivestmentsChange in CashChange in IntangiblesChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Exchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based CompensationShares IssuedShort-Term Debt issuances
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Idexx Laboratories (IDXX) Shares Issued (2016 - 2025)

Idexx Laboratories (IDXX) has 17 years of Shares Issued data on record, last reported at $17.9 million in Q4 2025.

  • For Q4 2025, Shares Issued rose 34.81% year-over-year to $17.9 million; the TTM value through Dec 2025 reached $93.4 million, up 109.84%, while the annual FY2025 figure was $93.4 million, 109.84% up from the prior year.
  • Shares Issued reached $17.9 million in Q4 2025 per IDXX's latest filing, down from $51.0 million in the prior quarter.
  • Across five years, Shares Issued topped out at $51.0 million in Q3 2025 and bottomed at $4.9 million in Q3 2022.
  • Average Shares Issued over 5 years is $13.4 million, with a median of $11.5 million recorded in 2022.
  • The widest YoY moves for Shares Issued: up 920.22% in 2025, down 65.55% in 2025.
  • A 5-year view of Shares Issued shows it stood at $9.1 million in 2021, then surged by 36.7% to $12.5 million in 2022, then dropped by 9.29% to $11.3 million in 2023, then increased by 16.99% to $13.3 million in 2024, then surged by 34.81% to $17.9 million in 2025.
  • Per Business Quant database, its latest 3 readings for Shares Issued were $17.9 million in Q4 2025, $51.0 million in Q3 2025, and $17.3 million in Q2 2025.